My ePortfolio Register   

SIOG 2015 /
Multicycle efficacy and safety of oral fixed combinations

12th - 14th Nov 2015

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 20.11.15
Views: 1153
Rating:

Prof Matti Aapro - Clinique de Genolier, Vaud, Switzerland

Prof Aapro talks to ecancertv at SIOG 2015 about the multicycle efficacy and safety of nepa, an oral fixed combination of netupitant and palonosetron, in older patients receiving chemotherapy of varying emetogenicity.

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence